Annovis Bio, Inc. Quarterly Liabilities, Current in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Annovis Bio, Inc. quarterly Liabilities, Current history and growth rate from Q4 2019 to Q3 2024.
Annovis Bio, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $5.39M, a 51.2% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$5.39M	+$1.83M	+51.2%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$4.06M	+$1.98M	+95.6%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$4.87M	-$541K	-10%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$4.28M	-$3.42M	-44.4%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$3.56M	+$1.04M	+41.1%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$2.07M	+$774K	+59.6%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$5.41M	+$4.01M	+287%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$7.7M	+$6.19M	+411%	Dec 31, 2022	10-K	2024-03-29
Q3 2022	$2.53M	+$1.41M	+125%	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	$1.3M	+$415K	+47%	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$1.4M	-$200K	-12.5%	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	$1.51M	+$928K	+160%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$1.12M	+$840K	+299%	Sep 30, 2021	10-Q	2021-11-03
Q2 2021	$884K	+$181K	+25.8%	Jun 30, 2021	10-Q	2021-07-28
Q1 2021	$1.6M	+$847K	+113%	Mar 31, 2021	10-Q	2021-05-06
Q4 2020	$578K	-$1.43M	-71.2%	Dec 31, 2020	10-K	2022-03-02
Q3 2020	$281K			Sep 30, 2020	10-Q	2020-11-04
Q2 2020	$703K			Jun 30, 2020	10-Q	2020-07-29
Q1 2020	$749K			Mar 31, 2020	10-Q	2020-05-05
Q4 2019	$2.01M			Dec 31, 2019	10-K	2021-03-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.